Shanghai MicroPort MedBot (Group) Co., Ltd. (stock code: 02252) announced that its board of directors will convene on Thursday, 26 March 2026.
The meeting agenda includes: 1. Reviewing and approving the Group’s audited financial statements for the year ended 31 December 2025. 2. Considering the recommendation of a final dividend, if any. 3. Transacting other routine corporate matters.
Board leadership remains unchanged, chaired by Dr. Zhaohua Chang, with executive directors Dr. Chao He and Mr. Yu Liu, five non-executive directors, and four independent non-executive directors.
The company will release its FY2025 results and any dividend proposal following the board’s consideration.
Comments